Columbia Journal of Pharmaceutical Sciences Login | Registration | Contact Us

ISSN Online: 2349-9907 | ISSN Print: 2350-014X
# Author Instruction
Columbia Journal of Pharmaceutical Sciences (CJPS) is an official journal of the Columbia Institute of Pharmacy, Raipur, India. CJPS is an international, peer-reviewed, multidisciplinary journal, devoted to pharmaceutical sciences. The CJPS seeks to set up an academic communicating platform for scientists all over the world. As well as contribute an international forum for all the researchers related to Pharmaceutical Sciences to share opinions and learn about important international breakthrough developments in drug discovery.
# Editorial Policy
CJPS is a quarterly journal, in English, which consider original research articles, rapid communications, letter to editor, reviews of recent advances, articles for educational forum, and interesting fillers. Articles concerning all aspects of Pharmaceutical sciences including Pharmaceutics, Pharmacology, Pharmacognosy, Natural Products, Medicinal Chemistry, Phytochemistry, Pharmaceutical Analysis, Quality Assurance, Green Chemistry, Pharmacogenomics, Drug Delivery Systems, Pharmacoinformatics, Pharmacovigilance, Pharmacokinetics, Drug Regulatory Affairs, Microbiology, Biotechnology, Toxicology, Plant Science, Plant Tissue Culture etc. will be considered.
# Submission declaration
Submission of a manuscript signifies that the work narrated has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication anywhere, that its publication is approved by all co-authors and tacitly or explicitly by the responsible authorities where Registered authors can keep track of their articles after logging into the site using their user name and password. If you experience any problems, please contact the editorial office by e-mail at editor@cjps.in .
# Contribution Details
Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure.
# Conflicts of Interest/ Competing Interests
All authors of submitting articles to the journal must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.
# Manuscript Preparation
Each manuscript should be typed double-spaced on A4 (8.5" × 11") paper size with 1 inch margins. Author should use 12 pt Times New Roman fonts, and authors should take care over the fonts which are used in the article.
# Manuscript should be arranged in the following order:
  • Covering letter
  • Title page
  • Abstract and Keywords
  • Introduction
  • Materials and Methods
  • Results
  • Discussion
  • Conclusion
  • Acknowledgement
  • References
  • Tables
  • Figures
# Abstract and Keywords
The abstract must start on a new page, and it should be concise, clear and informative rather than indicative. Provide 3-5 keywords which will help readers or indexing agencies in cross-indexing the study.
# Introduction
It should start on a new page. The introduction should lead the reader to the importance of the study; tie-up published literature with the aims of the study and clearly states the rationale behind the investigation.
# Material and methods
Materials and methods should include the source and nature of material, experimental design and the techniques employed. Methods already published should be indicated by a reference: only relevant modifications should be described. All procedures involving experimental animals or human subjects must accompany with statement on necessary ethical approval from appropriate ethics committee.
# Results
Results should be clear and concise.
# Discussion
The discussion should deal the interpretation of the results. Wherever possible, results and discussion can be combined. Results and discussion of results can also be combined under one section, Results and Discussion.
# Conclusions
A conclusion which elucidates the general implication of the results should be stated.
# Acknowledgments
Acknowledgments should be described separately. Authors should disclose at the time of submission, information on financial conflicts of interest or other interests that may influence the manuscript. captions. Tables should be numbered consecutively in Arabic numerals and bear a brief title in capital letters normal face. Tables should not be very large that they run more than one A4 sized page.
# Figures
Should be on separate pages but not inserted with in the text. Figures should be numbered consecutively in Arabic numerals and bear a brief title in lower case bold face letters below the figure. Graphs and bar graphs should preferably be prepared using Microsoft Excel and submitted as Excel graph pasted in Word.
# Errata and Corrections in Published Articles
Authors and readers are encouraged to notify the Editor-in-Chief if they discover errors in published content, authors’ names and affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases the journal will publish an ERRATUM in consultation with Editor-in-Chief and authors of the article, and/or replace or retract the article.
# Ethics and Consent
When reporting experiments on human subjects, authors should indicate whether the procedure follows were in accordance with the ethical standards of the responsible committee on human experimentation. Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Papers including animal experiments or clinical trials must be conducted with approval by the local animal care or human subject committees, respectively.
# Processing charges:
There is no processing, printing or handling charges for publication of manuscript. There is no processing fee for co-authors.
# Transfer of copyright agreement:
The work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder. The publisher will not be held legally responsible if there be any claims for compensation.
First of all, the editors review submitted manuscripts. The manuscripts with lacking originality, serious scientific and technical imperfections or short of a significant message are rejected.
CJPS follows the single-blind peer-review process for submissions of all manuscripts to its journals. Single-blind is the most common type of peer-reviewing in which the identity of the reviewers is not disclosed to the authors of the submitted manuscript concerned. The anonymity of reviewers allows for objective assessment of the manuscript by reviewers and also free from any influence by the authors on the reviewer's comments.
# Manuscript preparation
Manuscripts must comply to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” http://www.icmje.org/. Contributions and Manuscripts must be written in English and submitted exclusively to CJPS. Manuscripts must be typewritten (double-spaced) with liberal margins and space at the top and bottom of the page.
CJPS uses an online submission system, which enables authors to submit papers via the Web (Online Manuscript Submission) or editor@cjps.in. Author will be guided stepwise through the creation and uploading of your files. First-time users will have to register at this site. Registration is free but mandatory.
# Article structure Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Any subsection may be given a brief heading. Each heading should appear on its own separate line.
# Covering Letter
In addition to the general details of author and co-authors, it should mention in brief what is already known about this subject and what new is added by the submitted work.
# Title page
It should be paginated as page 1 of the paper. It should include the title, author’s name and affiliations, running title, address for correspondence including e-mail address.
# Title:
Must be informative, specific and short.
# Authors and affiliations
The names of authors and their affiliations should be given. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name.
# Running title
It is a short title printed in the journal at the right top corner of right hand page of the article (except the lead page). It should be not more than 50 characters in length.
# Address for correspondence
The corresponding author’s address should be given on the title page. The e-mail ID of the corresponding author or the contact e-mail ID must also be provided.
# References
All references must be complete and accurate. The titles of journals should be abbreviated according to the "List of Journals Indexed" in Index Medicus (www.nlm.nih.gov). List all authors, for more than 6 authors the first 6 should be listed followed by "et al." References are to be cited in the text by superscript number and should be in the order in which they appear. References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration.
# References should be listed in the following style:
Reference to a journal publication:
Adil MD, Kaiser P, Satti NK, Zargar AM, Vishwakarma RA, Tasduq SA. Effect of Emblica officinalis (fruit) against UVB-induced photo-aging in human skin fibroblasts. J. Ethnopharmacol. 2010; 132(1): 109-14.
Nema NK, Maity N, Sarkar B, Mukherjee PK. Cucumis sativus fruit-potential antioxidant, anti-hyaluronidase and anti-elastase agent. Arch. Dermatol. Res. 2011; 303: 247-52.
# Reference to a book:
Kirtikar KR, Basu BD. Indian Medicinal Plant. Vol. I. 3rd ed. Dehradun: I.B.D. Publications; 2010, 756.
# Reference to a chapter in an edited book:
Saggar S, Wesley NO. Ethnic Differences in Skin Properties. In: Barel AO, Paye M, Maibach HI, editors. Handbook of Cosmetic Science and Technology. 3rd ed. New York: E-Publishing Inc; 2009, 245-246.
#Tables
Should be typed on separate sheets of paper and should not preferably contain any molecular structures. Tables should show lines separating columns but not those separating rows except for the top row that shows column The article entitled _________________________________is herewith submitted for publication in Columbia Journal of Pharmaceutical Sciences (CJPS). It has not been published before, and it is not under consideration for publication in any other journal (s). It contains no matter that is scandalous, obscene, libelous, or otherwise contrary to law. When the article is accepted for publication, I/We, as author/authors, hereby agree to transfer to Columbia Journal of Pharmaceutical Sciences (CJPS) all rights, including those pertaining to electronic forms and transmissions, under existing copyright laws.
I/We agree that copies made under these circumstances will continue to carry the copyright notice that appeared in the original published work. I/We certify that I/We have obtained written permission for the use of text, tables, and/or illustrations from any copyrighted source(s), and I/We agree to supply such written permission(s) to Columbia Journal of Pharmaceutical Sciences (CJPS) upon request.
Name(s) and designation Signature of Name(s) of Institution/ Organization
© 2014 CJPS All Right Reserved Developed By Shaurya Technologies